Investors & News

Investor Relations

Stock price graph
     

MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.

Recent Releases

May 4, 2012
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results

May 1, 2012
MAP Pharmaceuticals to Present at Upcoming Investor Conferences

Apr 12, 2012
MAP Pharmaceuticals Provides Update on LEVADEX® Program

View all »   RSS

 

 

Stock Quote
(NASDAQ:MAPP)

Price:
11.69
Change:
+ 0.15
Day High:
11.73
Day Low:
11.46
Volume:
280,800
4:00 PM ET on May 17, 2012
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools